208 results on '"Kril, Jillian J."'
Search Results
2. MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study
3. Targeting 14-3-3θ-mediated TDP-43 pathology in amyotrophic lateral sclerosis and frontotemporal dementia mice
4. Distribution Patterns of Astrocyte Populations in the Human Cortex
5. MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study
6. Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG).
7. Globular glial tauopathy with a mutation in MAPT and unusual TDP-43 proteinopathy in a patient with behavioural-variant frontotemporal dementia
8. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy
9. Defining early changes in Alzheimer’s disease from RNA sequencing of brain regions differentially affected by pathology
10. Author Correction: Defining early changes in Alzheimer’s disease from RNA sequencing of brain regions differentially affected by pathology
11. Heritability in frontotemporal tauopathies
12. Impact of small vessel disease on severity of motor and cognitive impairment in Parkinson’s disease
13. Imaging mass spectrometry of frontal white matter lipid changes in human alcoholics
14. Cellular and regional vulnerability in frontotemporal tauopathies
15. Neuroinflammation in frontotemporal dementia
16. Treatment with the copper compound CuATSM has no significant effect on motor neuronal pathology in patients with ALS
17. Mouse models of frontotemporal dementia: A comparison of phenotypes with clinical symptomatology
18. Assessment of amyloid β in pathologically confirmed frontotemporal dementia syndromes
19. Altered serum protein levels in frontotemporal dementia and amyotrophic lateral sclerosis indicate calcium and immunity dysregulation
20. The underacknowledged PPA-ALS: A unique clinicopathologic subtype with strong heritability
21. Creating the Pick’s disease International Consortium: Association study ofMAPTH2 haplotype with risk of Pick’s disease
22. The frontotemporal dementia-motor neuron disease continuum
23. Distinctive pathological mechanisms involved in primary progressive aphasias
24. Expanding the phenotypic associations of globular glial tau subtypes
25. Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration
26. Is the logopenic-variant of primary progressive aphasia a unitary disorder?
27. Riluzole is associated with decreasing neuritic plaque severity in amyotrophic lateral sclerosis
28. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies
29. Distribution Patterns of Astrocyte Populations in the Human Cortex
30. Microglial proliferation in the brain of chronic alcoholics with hepatic encephalopathy
31. Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis
32. Cerebellar Neuronal Loss in Amyotrophic Lateral Sclerosis Cases With ATXN2 Intermediate Repeat Expansions
33. Early-onset axonal pathology in a novel P301S-Tau transgenic mouse model of frontotemporal lobar degeneration
34. Lipidome Changes in Alcohol‐Related Brain Damage
35. Glycoprotein Pathways Altered in Frontotemporal Dementia With Autoimmune Disease
36. Cortical Function in Asymptomatic Carriers and Patients With C9orf72 Amyotrophic Lateral Sclerosis
37. TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes
38. OPINION: FTD and ALS—translating mouse studies into clinical trials
39. Association Between Globular Glial Tauopathies and Frontotemporal Dementia—Expanding the Spectrum of Gliocentric Disorders
40. Coexisting Lewy body disease and clinical parkinsonism in amyotrophic lateral sclerosis
41. Ground state depletion microscopy as a tool for studying microglia–synapse interactions
42. Riluzole is associated with decreasing neuritic plaque severity in amyotrophic lateral sclerosis.
43. A Practical Approach to Differentiate the Frontotemporal Tauopathy Subtypes
44. Lipidome changes in alcohol‐related brain damage.
45. CNS cell type–specific gene profiling of P301S tau transgenic mice identifies genes dysregulated by progressive tau accumulation
46. Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders
47. Chronic Traumatic Encephalopathy (CTE) Is Absent From a European Community-Based Aging Cohort While Cortical Aging-Related Tau Astrogliopathy (ARTAG) Is Highly Prevalent
48. Reply: Will FTLD-tau work for all when FTDP-17 retires?
49. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies
50. Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.